Bio-Rad to Participate in the Bank of America Merrill Lynch Health Care Conference 2019 in May

HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life
science research and clinical diagnostic products, today announced that
Norman Schwartz, President and CEO, and Ilan Daskal, Executive Vice
President and CFO, will participate in the Bank of America Merrill Lynch
Health Care Conference 2019 on May 14, at 10:40 AM Pacific Time, at the
Encore Hotel, Las Vegas, Nevada.

A link to the live audio webcast of the Fireside Chat will be available
in the Investor Relations area of our website at www.bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in
developing, manufacturing, and marketing a broad range of innovative
products for the life science research and clinical diagnostic markets.
With a focus on quality and customer service for over 65 years, our
products advance the discovery process and improve healthcare. Our
customers are university and research institutions, hospitals, public
health and commercial laboratories, biotechnology, pharmaceutical, as
well as applied laboratories that include food safety and environmental
quality. Founded in 1952, Bio-Rad is based in Hercules, California, and
has a global network of operations with more than 8,000 employees
worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018. For more
information, please visit www.bio-rad.com.

Contacts

Bio-Rad Laboratories, Inc.
Tina Cuccia, Corporate Communications
510-724-7000
[email protected]